Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,369 | -6,734 | -25,322 | -18,309 | -12,241 |
| Depreciation Amortization | 745 | 355 | 1,172 | 834 | 590 |
| Accounts receivable | 158 | 260 | -296 | -2 | 104 |
| Accounts payable and accrued liabilities | 3,106 | 268 | 472 | 1,066 | 1,270 |
| Other Working Capital | 2,365 | -114 | 409 | 19 | 279 |
| Other Operating Activity | -1,107 | 614 | 2,209 | 674 | -213 |
| Operating Cash Flow | $-8,102 | $-5,353 | $-21,356 | $-15,720 | $-10,212 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -663 | -130 | -1,227 | -1,077 | -801 |
| Purchase Sale Intangibles | -1,000 | -500 | N/A | N/A | N/A |
| Other Investing Activity | -1,000 | -500 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,663 | $-630 | $-1,227 | $-1,077 | $-801 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 4,892 | N/A | N/A |
| Debt Repayment | -1,759 | -370 | -137 | N/A | N/A |
| Common Stock Issued | 7,941 | 4,930 | 20,120 | 20,120 | 20,127 |
| Other Financing Activity | 0 | 0 | -500 | 0 | 0 |
| Financing Cash Flow | $6,181 | $4,560 | $24,375 | $20,120 | $20,127 |
| Beginning Cash Position | 7,723 | 7,723 | 5,931 | 5,931 | 5,931 |
| End Cash Position | 4,139 | 6,301 | 7,723 | 9,254 | 15,046 |
| Net Cash Flow | $-3,584 | $-1,422 | $1,792 | $3,323 | $9,115 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,102 | -5,353 | -21,356 | -15,720 | -10,212 |
| Capital Expenditure | -663 | -130 | -1,227 | -1,077 | -801 |
| Free Cash Flow | -8,765 | -5,482 | -22,583 | -16,797 | -11,012 |